Patents by Inventor Christine Elizabeth Allan

Christine Elizabeth Allan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzylamine derivatives
    Patent number: 9834513
    Abstract: The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R1 to R3, R5 to R9, A, P, V, W, X, Y and Z are as defined herein.
    Type: Grant
    Filed: May 23, 2017
    Date of Patent: December 5, 2017
    Assignee: Kalvista Pharmceuticals Limited
    Inventors: Christine Elizabeth Allan, Andrzej Roman Batt, Rebecca Louise Davie, Hannah Joy Edwards, David Michael Evans, Stephen John Pethen
  • Benzylamine Derivatives
    Publication number: 20170253561
    Abstract: The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R1 to R3, R5 to R9, A, P, V, W, X, Y and Z are as defined herein.
    Type: Application
    Filed: May 23, 2017
    Publication date: September 7, 2017
    Inventors: Christine Elizabeth Allan, Andrzej Roman Batt, Rebecca Louise Davie, Hannah Joy Edwards, David Michael Evans, Stephen John Pethen
  • Benzylamine derivatives
    Patent number: 9670157
    Abstract: The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R1 to R3, R5 to R9, A, P, V, W, X, Y and Z are as defined herein.
    Type: Grant
    Filed: January 8, 2014
    Date of Patent: June 6, 2017
    Assignee: Kalvista Pharmaceuticals Limited
    Inventors: Christine Elizabeth Allan, Andrzej Roman Batt, Rebecca Louise Davie, Hannah Joy Edwards, David Michael Evans, Stephen John Pethen
  • BENZYLAMINE DERIVATIVES
    Publication number: 20160039752
    Abstract: The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R1 to R3, R5 to R9, A, P, V, W, X, Y and Z are as defined herein.
    Type: Application
    Filed: January 8, 2014
    Publication date: February 11, 2016
    Inventors: Christine Elizabeth ALLAN, Andrzej Roman BATT, Rebecca Louise DAVIE, Hannah Joy EDWARDS, David Michael EVANS, Stephen John PETHEN
  • Amphetamine Prodrugs
    Publication number: 20140073589
    Abstract: The present invention relates to amphetamine prodrugs which provide colonic release of amphetamine.
    Type: Application
    Filed: June 26, 2013
    Publication date: March 13, 2014
    Inventors: Rhys WHOMSLEY, Christine Elizabeth Allan, Timothy Jon Luker
  • Aminopyridine Derivatives
    Publication number: 20100076015
    Abstract: The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in therapy (such as asthma or COPD); and methods of treating patients with such compounds; wherein R1-R11 are as defined herein.
    Type: Application
    Filed: April 28, 2009
    Publication date: March 25, 2010
    Applicant: VANTIA LIMITED
    Inventors: David Michael Evans, Christine Elizabeth Allan, John Horton, David Philip Rooker